A phase 2 open label randomized dose and schedule finding clinical trial of immunotherapy with AMG 412 [epratuzumab] in subjects with diffuse large B-cell non-Hodgkin's lymphoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2007
At a glance
- Drugs Epratuzumab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 29 Oct 2007 Status changed from suspended to in progress.
- 27 Sep 2005 New trial record.